U.S. Immune Repertoire Sequencing Market Size & Outlook
Related Markets
U.S. immune repertoire sequencing market highlights
- The U.S. immune repertoire sequencing market generated a revenue of USD 126.2 million in 2024 and is expected to reach USD 348.4 million by 2033.
- The U.S. market is expected to grow at a CAGR of 12% from 2025 to 2033.
- In terms of segment, assay kits & reagents was the largest revenue generating product & service in 2024.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Immune repertoire sequencing market data book summary
| Market revenue in 2024 | USD 126.2 million |
| Market revenue in 2033 | USD 348.4 million |
| Growth rate | 12% (CAGR from 2025 to 2033) |
| Largest segment | Assay kits & reagents |
| Fastest growing segment | Services |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Assay Kits & Reagents, Services |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.5% of the global immune repertoire sequencing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. immune repertoire sequencing market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 348.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immune Repertoire Sequencing Market Scope
Immune Repertoire Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Celemics | View profile | 51-100 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | http://www.celemics.com |
| iRepertoire | View profile | 11-50 | Huntsville, Alabama, United States, North America | https://www.irepertoire.com/ |
| Illumina, Inc. | View profile | - | - | - |
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | https://www.genomics.cn/ |
| Creative-Biolabs | View profile | 51-100 | Shirley, New York, United States, North America | https://www.creative-biolabs.com |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
U.S. immune repertoire sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immune repertoire sequencing market will help companies and investors design strategic landscapes.
Assay kits & reagents was the largest segment with a revenue share of 55.31% in 2024. Horizon Databook has segmented the U.S. immune repertoire sequencing market based on instruments, assay kits & reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to U.S. immune repertoire sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. immune repertoire sequencing market databook
-
Our clientele includes a mix of immune repertoire sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. immune repertoire sequencing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. immune repertoire sequencing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
US Product & Service - Immune Repertoire Sequencing Market size, 2024 - 2033 (US$M)
U.S. Immune Repertoire Sequencing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
